Sage Capital Advisors’s Abiomed Inc ABMD Stock Holding History

Sage Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-504	Closed	-$206K	–	94
2018 Q2	$206K	Buy	+504	New	+$183K	0.14%	81

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sage Capital Advisors's ABMD Position: Q3 2018 in Review

Sage Capital Advisors sold out of Abiomed Inc (ABMD) in Q3 2018, closing a stake of 504 shares — an estimated $206K sold.

Sage Capital Advisors first reported a position in ABMD in Q2 2018 and held it in 1 quarter. The position peaked at $206K in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q3 2018.

Sage Capital Advisors reported no remaining Abiomed Inc position as of Q3 2018 after selling out during the quarter.
Sage Capital Advisors sold 504 Abiomed Inc shares in Q3 2018, an estimated $206K.
Sage Capital Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 1 quarter.
Sage Capital Advisors's Abiomed Inc position peaked at $206K in Q2 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2018.

Based on Sage Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.